University Hospital
Welcome,         Profile    Billing    Logout  
 60 Trials 
18 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Blanc, François-Xavier
BENRAPRED, NCT04565483: Predictive Signature of Benralizumab Response

Recruiting
4
220
Europe
Benralizumab Prefilled Syringe, Transcriptomic
Nantes University Hospital, AstraZeneca, Ministère de la Santé - France
Asthma; Eosinophilic, Severe Asthma
10/26
11/26
NIMBLE, NCT04718389 / 2020-003612-28: A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype

Hourglass Feb 2024 - Jun 2024 : Acceptance of regulatory submission in China for CRSwNP
Active, not recruiting
3
1667
Europe, Canada, Japan, US, RoW
GSK3511294 (Depemokimab), Mepolizumab, Benralizumab, Placebo, Standard of care (SoC), Pre-filled Syringes (PFS)
GlaxoSmithKline, Iqvia Pty Ltd
Asthma
10/25
10/25
Rialland, Fanny
TAK-620-2004, NCT05319353 / 2021-004279-15: A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT)

Active, not recruiting
3
80
Europe, Japan, US, RoW
Maribavir, TAK-620
Takeda, Takeda Development Center Americas, Inc.
Cytomegalovirus (CMV)
01/27
01/27
Cariou, Bertrand
NCT06292013: A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)

Recruiting
3
12500
Europe, Canada, Japan, US, RoW
Lepodisiran Sodium, LY3819469, Placebo
Eli Lilly and Company
Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a)
03/29
03/29
NATiV3, NCT04849728: A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( )

Recruiting
3
1000
Europe, Canada, US, RoW
IVA337, Lanifibranor, Placebo
Inventiva Pharma
NASH - Nonalcoholic Steatohepatitis
09/25
09/26
SURMOUNT-MMO, NCT05556512: A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity

Active, not recruiting
3
15374
Europe, Canada, Japan, US, RoW
Tirzepatide, LY3298176, Placebo
Eli Lilly and Company
Obesity, Overweight
10/27
10/27
MAGNAN, Antoine
BENRAPRED, NCT04565483: Predictive Signature of Benralizumab Response

Recruiting
4
220
Europe
Benralizumab Prefilled Syringe, Transcriptomic
Nantes University Hospital, AstraZeneca, Ministère de la Santé - France
Asthma; Eosinophilic, Severe Asthma
10/26
11/26
NIMBLE, NCT04718389 / 2020-003612-28: A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype

Hourglass Feb 2024 - Jun 2024 : Acceptance of regulatory submission in China for CRSwNP
Active, not recruiting
3
1667
Europe, Canada, Japan, US, RoW
GSK3511294 (Depemokimab), Mepolizumab, Benralizumab, Placebo, Standard of care (SoC), Pre-filled Syringes (PFS)
GlaxoSmithKline, Iqvia Pty Ltd
Asthma
10/25
10/25
BARBAROT, Sébastien
TRALO-Oeil, NCT05682976: Ophthalmological Adverse Events of Tralokinumab in AD

Not yet recruiting
N/A
100
Europe
Nantes University Hospital, LEO Pharma
Atopic Dermatitis
07/25
03/26
CHAILLOUS, Lucy
BETTER, NCT05628532: DBLG1 System With TERUMO MEDISAFE WITH Insulin Pump Trial

Completed
N/A
90
Europe
Use of the DBLG1 system
Diabeloop, Icadom
Diabetes Mellitus, Type 1
02/24
04/24
SEECLOOP, NCT06363916: Evaluation of Security and Efficacy of Medtrum Hybrid Closed Loop System

Recruiting
N/A
160
Europe
Insulin Management System in Manual mode of operation, Insulin Management System in Automatic mode of operation
Medtrum France, Axonal-Biostatem
Type 1 Diabetes
11/25
12/25
SP12, NCT04749693: Observational Study of the Use of DBLG1 System in Real Life

Recruiting
N/A
348
Europe
DBLG1 System
Diabeloop
Type1diabetes
07/25
01/26
ROQUILLY, Antoine
RECOVER, NCT06370598: Phase 1/2a to Assess the Safety and Tolerability of TP-122A for the Treatment of Ventilator-Associated Pneumonia

Not yet recruiting
1/2
15
Europe
TP-122A
Technophage, SA, VectorB2B
Pneumonia, Ventilator-Associated
05/25
06/25
ROUAUD, Tiphaine
PIMPARK, NCT03947216: Randomized Placebo Controlled Trial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5-HydroxyTryptamine-2A (5HT2A) Inverse Agonist, to Treat Impulse Control Disorders in Parkinson's Disease.

Completed
2
117
Europe
Active drug: pimavanserin 17mg (2 strength tablets), Placebo: 2 tablets containing same excipients except active compound, Assessment of severity of ICD (impulse control disorders), Assessment of motor and non-motors symptoms of PD Evaluation of hyper- and hypodopaminergic behaviors, Assessment of quality of life, Assessment of depression, Assessment of cognition, Assessment of severity of Parkinson Disease, Blood analysis, Cardiac monitoring
University Hospital, Strasbourg, France, NS-PARK, EUCLID Clinical Trial Platform, F-CRIN, ACADIA Pharmaceuticals Inc.
Parkinson Disease
04/24
06/24
GUILLON, Benoit
CLOSE-2, NCT05387954: PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years

Recruiting
3
792
Europe
Transcatheter PFO closure, •Each device for PFO closure must have the CE mark, •and be approved by the Interventional Cardiology Committee, Oral Anticoagulant, Direct-Acting, Antiplatelet therapy
Assistance Publique - Hôpitaux de Paris, Ministry of Health, France, W.L.Gore & Associates, Abbott, Occlutech International AB, Centre Hospitalier St Anne
Cryptogenic Ischemic Stroke, Patent Foramen Ovale
07/31
07/31
Figueres, Lucile
FALCON, NCT03918447 / 2018-004651-20: A Trial of Bardoxolone Methyl in Patients With ADPKD -

Terminated
3
667
Europe, Japan, US, RoW
Bardoxolone methyl oral capsule, RTA 402, Placebo oral capsule
Reata, a wholly owned subsidiary of Biogen, Reata Pharmaceuticals, Inc., REATA PHARMACEUTICALS, INC
Autosomal Dominant Polycystic Kidney, ADPKD
08/23
08/23
XLHRegistry, NCT03193476: Registry for Patients With X-Linked Hypophosphatemia

Recruiting
N/A
1343
Europe, RoW
Kyowa Kirin Pharmaceutical Development Ltd, Iqvia Pty Ltd
X-Linked Hypophosphatemia
02/29
07/29
BREBION, Nicolas
API-CAT, NCT03692065 / 2017-003342-25: STUDY for APIxaban Cancer Associated Thrombosis

Completed
3
1766
Europe, Canada
Apixaban 5 MG, Apixaban 2.5 MG
Assistance Publique - Hôpitaux de Paris, Bristol-Myers Squibb
Cancer-associated Thrombosis
09/24
10/24
BULTEAU
No trials found
RAT, Cedric
No trials found
RAT, Cédric
No trials found
FOURNIER, Jean-Pascal
No trials found
BANASZUK, Anne-Sophie
No trials found
GANDONNIERE, Charlotte SALMON
No trials found
Ingles, Hugo
No trials found

Download Options